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The UL24 gene of herpes simplex virus overlaps the viral thymidine kinase (tk) gene. Most previous studies of UL24 have
examined UL24 mutants that have also contained tk and sometimes other mutations. To address the importance of UL24 for
viral replication in cell culture and in infections of a mammalian host, we constructed a mutant virus containing a UL24
nonsense mutation that does not affect TK activity and a second mutant that contains clustered point mutations in UL24 and
a mutation in tk that does not by itself affect the ability of the virus to replicate acutely in mouse ganglia or to reactivate from
latent infection following corneal inoculation of mice. Both mutant viruses replicated in cells in culture and in the mouse eye,
albeit less efficiently than wild type or control viruses. Both mutants were much more severely impaired for acute replication
in trigeminal ganglia and for reactivation from latency following explant of these ganglia. Viral DNA and latency-associated
transcripts were present, albeit at lower levels in ganglia infected with the nonsense mutant. These results indicate that UL24
is especially important for productive infection of mouse sensory ganglia and may have implications for the behaviors of
certain tk mutants in pathogenesis. © 1998 Academic Press
INTRODUCTION
Herpes simplex virus (HSV) encodes numerous genes
that are not essential for viral replication in cell culture
(Roizman and Sears, 1996). One such gene, UL24, was
originally identified as the 24th open reading frame (ORF)
in the unique long segment of HSV-1 DNA. Although the
protein product of the UL24 gene (UL24) has not, to our
knowledge, been identified in infected cells, much evi-
dence indicates that UL24 is expressed during produc-
tive infection. RNA transcripts have been mapped that
could potentially encode UL24 (Cook and Coen, 1996;
Holland et al., 1984; Kibler et al., 1991; Read et al., 1984;
Read and Summers, 1982; Wilkie et al., 1980) ORFs ho-
mologous to UL24 have been found in alpha, beta, and
gamma herpesviruses and in viruses as diverse as chan-
nel catfish herpesvirus and human herpesvirus 8 (Davi-
son, 1992; Dezelee et al., 1996; Jacobson et al., 1989;
Moore et al., 1996). A number of mutants with UL24
lesions exhibit a reduced ability to replicate in tissue
culture (Jacobson et al., 1989; Sanders et al., 1982) as
well as a syncytial plaque phenotype (Sanders et al.,
1982). These phenotypes correlate with alterations in
regions of amino acid sequence conserved among her-
pesviruses (Jacobson et al., 1989). However, the UL24
mutants that exhibited replication defects contained le-
sions in the viral thymidine kinase (tk) gene, whose 59
end overlaps the 59 end of UL24. Some of these viruses
have also contained other mutations. In contrast, a TK-
competent mutant that contains a syncytial mutation that
maps to UL24 replicated as efficiently as its wild-type
parent (Tognon et al., 1990). Thus, it has not been shown
that UL24 mutations result in replication defects in an
otherwise wild-type background. Moreover, the effects of
such mutations on replication and viral latency in an
animal model have not been investigated.
Mutations such as deletions that completely inactivate
viral TK (TK2 mutations) without effects on UL24 severely
impair acute ganglionic replication and reactivation from
latency in mice (Coen et al., 1989a,b; Efstathiou et al.,
1989; Jacobson et al., 1993). However, because UL24
overlaps the tk gene, many studies that focused on the
effects of tk mutations on viral replication and latency
used viruses containing mutations that might be ex-
pected to alter UL24 (Ho and Mocarski, 1988; Leist et al.,
1989; Meignier et al., 1988; Sears et al., 1985). Some of
these mutations do not alter the tk ORF and thus con-
ceivably could express low levels of TK (TK-partial). In
contrast to TK2 mutants, TK-partial mutants are often
substantially competent for viral replication and reacti-
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vation from latency in mice (Coen et al., 1989a; Gordon et
al., 1983; Jacobson et al., 1995; Tenser et al., 1981). We
therefore investigated the phenotypes of a UL24 single
mutant and tested whether the presence of a UL24 mu-
tation would modify the phenotype of a TK-partial mutant
that is otherwise competent for ganglionic replication
and reactivation from latency.
RESULTS
Construction of a TK1, UL24 mutant
Previous studies that reported an effect of UL24 mu-
tations on viral replication in cell culture used mutants
containing a deletion in tk (Sanders et al., 1982) or mu-
tants containing a nonsense mutation in tk that leads to
expression of low levels of a truncated but otherwise
active TK polypeptide together with an alteration in pol
(Jacobson et al., 1989). To clarify the role of UL24 in cell
culture and to determine its role in infection of a mam-
malian host, it was necessary to construct virus contain-
ing UL24 mutations within a wild-type background. The
design of a mutation in UL24 that would not be expected
to alter expression of another gene product was compli-
cated by the fact that UL24 not only overlaps the tk gene
and its promoter (see Fig. 1), but may also overlap the
UL25 promoter and 59 untranslated region (Addison et
al., 1984; Coen et al., 1986; Holland et al., 1984; Jacobson
et al., 1989; McGeoch et al., 1988). Although portions of
the tk promoter are known not to be necessary for effi-
cient tk expression in cell culture (Boni and Coen, 1989;
Coen et al., 1986; Imbalzano et al., 1991), we did not wish
to alter these regions in case they play a role in a
mammalian host.
Small insertions at the BglII site in the tk 59 untrans-
lated region have been shown to have little or no effect
on tk expression (Pelletier and Sonenberg, 1985). There-
fore a UL24 mutation was constructed by inserting an
XbaI linker with nonsense mutations in all reading
frames into pKOS17B2 at that site, creating pKOS17-
B2Xba. This mutation was transferred into the virus by
marker rescue, using infectious DNA prepared from
tkLTRZ1. This recombinant virus expresses bacterial
b-galactosidase due to the presence of a lacZ gene
inserted in tk and thus forms blue plaques in the pres-
FIG. 1. The UL24 ORF of HSV-1. The nucleotide sequence beginning with the ATG predicted to be the UL24 initiation codon is shown with the
predicted UL24 protein sequence shown below it in single letter code. Under the first line of UL24 sequence is shown the overlapping predicted TK
protein sequence. Indicated by shading are the locations of domains (Regions I–V) conserved among various herpesvirus homologs of UL24
(Jacobson et al., 1989; Dezelee et al., 1996) and the location of the tk mRNA start site. Indicated by underlining is the tk TATA box. The amino acids
changed by the LS-16/-6 mutation are provided below the third line of UL24 sequence.
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ence of X-gal. The strategy was to rescue the lacZ inser-
tion with pKOS17B2Xba and then to screen progeny virus
that formed white plaques for loss of the lacZ insert and
substitution of an XbaI site for the BglII restriction site by
PCR. Viruses that met this criteria were plaque purified to
homogeneity. Two independent isolates (from two inde-
pendent transfections) were obtained and designated
UL24XB and UL24XG. Southern blot analysis (not shown)
demonstrated that the BamHI P fragments were the ex-
pected size, did not contain the lacZ insert, and did
contain the novel XbaI site instead of the BglII site. This
is expected to result in termination of UL24 after 53
amino acids (about 18% of the total 269 amino acid open
reading frame).
We then tested UL24XB and UL24XG for TK activity in
an enzymatic assay of infected cell extracts. Both exhib-
ited activity indistinguishable from that of wild-type strain
KOS, while tkLTRZ1 did not exhibit TK activity above that
of mock-infected cells (Fig. 2).
Construction of a TK-partial, UL24 double mutant
Among the numerous reports on the effect of tk muta-
tions on productive infection and reactivation from la-
tency in a mammalian host, some of the viruses used in
these studies were UL24–tk double mutants (Ho and
Mocarski, 1988; Leist et al., 1989; Meignier et al., 1988;
Sears et al., 1985). We constructed a UL24–TK-partial
double mutant to determine if it would differ in phenotype
from TK2 or TK-partial single mutants. To do this, we took
advantage of the existence of the virus LS-16/-6, a UL24–
tk–pol triple mutant with wild-type tk promoter activity
(Coen et al., 1986; Jacobson et al., 1989). LS-16/-6, which
contains clustered point mutations in UL24, exhibits the
small plaque and decreased burst size characteristic of
UL24 mutants and is no less impaired for these pheno-
types than UL24 frameshift or nonsense mutants (Jacob-
son et al., 1989, and unpublished results; see also be-
low). The tk mutation in LS-16/-6, derived from mutant
KG111, reduces TK activity to 5–10% of wild-type levels.
This mutation by itself has no discernible effect on the
ability to replicate in the mouse eye and trigeminal gan-
glia and to establish a reactivatable latent infection
(Coen et al., 1989a). However, when the pol mutation in
LS-16/-6, which is derived from mutant PAAr5, is com-
bined with this tk mutation, the resulting double mutant is
drastically impaired for ganglionic replication and reac-
tivation (Jacobson et al., 1995).
We therefore rescued the pol mutation of LS-16/-6,
which confers hypersensitivity to aphidicolin and resis-
tance to phosphonoacetic acid (PAA) (Coen et al., 1984,
1983), scoring for progeny virus that exhibited wild-type
susceptibility to aphidicolin. The wild-type pol sequence
used for rescue, a 1.7-kbp KpnI fragment, increased the
frequency of virus that could form plaques in 0.5 mg/ml
aphidicolin by .1000-fold. Virus from one such plaque
that formed in 0.5 mg/ml aphidicolin exhibited wild-type
susceptibilities to PAA and aphidicolin (data not shown).
This virus was plaque-purified twice more and desig-
nated LS-16/-6RP. DNA sequence analysis confirmed
that the PAAr5 mutation (a serine at codon 842) had been
rescued to wild type (arginine).
Replication in cell culture
UL24–tk–pol triple mutants such as LS-16/-6 make
smaller than wild-type plaques and produce fewer
plaque forming units (PFUs) per cell in a single cycle
growth assay (Jacobson et al., 1989). To determine if this
is also true when the UL24 mutation exists in an other-
wise wild-type background or in the presence of a TK-
partial mutation only, the average plaque size for each
virus was determined and single cycle growth assays
were performed to assess the ability of the UL24 mutants
to grow in tissue culture (Table 1). The viruses mainly fell
into two groups, the members of which were indistin-
guishable from each other. KOS, KG111, and tkLTRZ1
replicated efficiently in a single cycle of infection (burst
size ;100 PFU/cell). In contrast, UL24XB, UL24XG, and
LS-16/-6RP—all viruses containing UL24 mutations—
replicated about fivefold less efficiently in a single cycle
of infection (burst size ;20 PFU/cell). Similarly, UL24XB,
UL24XG, and LS-16/-6RP formed smaller plaques than
did the other viruses. Although the differences in plaque
size between the two groups were small, they were
statistically significant (Table 1). The UL24–tk–pol triple
mutant LS-16/-6 exhibited a slightly smaller burst size
than the other UL24 mutants and the smallest plaque
size of the mutants tested; however, its plaque size was
not significantly different from that of the rescued virus
LS-16/-6RP which is a UL24–tk double mutant (Table 1).
LS-16/-6RP, UL24XB, and UL24XG also displayed a syn-
FIG. 2. TK activities. Vero cells were mock-infected (mock) or infected
with the indicated viruses, harvested at 8.5 h postinfection, and as-
sayed for TK activity for the indicated periods of time. Activities were
normalized to that observed with KOS-infected cells at 2 h, which was
set as 100%.
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cytial plaque phenotype (data not shown) similar to that
reported for other known or likely UL24 mutants (Jacob-
son et al., 1989; Sanders et al., 1982; Tognon et al., 1990).
Thus, the UL24 mutants exhibited reduced replication
and small plaque phenotypes in cell culture in the ab-
sence of tk and pol mutations.
Replication and reactivation from latency
The UL24 mutants were then tested for their ability to
replicate and reactivate from latency following corneal
inoculation of mice (Table 2). The triple mutant LS-16/-6
exhibited a 1000-fold reduction in virus titers in eye-
swabs compared to wild-type strain KOS. In contrast,
UL24XB, UL24XG, and LS-16/-6RP replicated substan-
tially more efficiently than LS-16/-6, with titers in eye-
swabs that were consistently 30- to 100-fold higher.
These titers were 10- to 30-fold reduced from those of
wild-type virus, consistent with the modest reductions in
burst size observed in cell culture.
All of the UL24 mutants exhibited dramatic deficien-
cies in their ability to replicate in ganglia 3 days postin-
oculation (Table 2). The triple mutant LS-16/-6 exhibited
no detectable ganglionic replication. This result was
expected as PKG7, which contains the tk and pol muta-
tions of LS-16/-6 without a UL24 mutation, also fails to
detectably replicate in ganglia (Jacobson et al., 1995).
Nevertheless, no replication was observed in 8 ganglia
from mice infected with the TK-partial, UL24 double mu-
tant LS-16/-6RP in marked contrast to the TK-partial sin-
gle mutant KG111, which replicates indistinguishably
from wild-type strain KOS (Coen et al., 1989a; Jacobson et
al., 1995). Similarly, replication was severely impaired in
the ganglia of mice infected with the two UL24 single
mutants UL24XB and UL24XG. Only 1 ganglion of 10
infected with UL24XB and only 1 ganglion of 4 infected
with UL24XG contained infectious virus. In each case
there was only one or a few PFU per ganglion, which
could be the result of low level replication in the ganglia
or contamination from the eye during the dissection of
the ganglia.
Reactivation from latently infected ganglia was as-
sessed using two assays, one in which ganglia were
explanted, cut into eight pieces, and cocultivated with
Vero cells and the other where the ganglia were disso-
ciated into single cells and plated onto Vero cells (Table
2). The triple mutant LS-16/-6 failed to reactivate in either
assay from a total of 20 ganglia, as expected from the
TABLE 1
Yield and Plaque Size Phenotypesa
Virus
Burst sizeb
(%)
Mean plaque
size (mm)c
KOS 128 (100) 1.7
KG111 96 (75) 1.7
tkLTRZ1 100 (78) 1.7
UL24XB 22 (17) 1.5
UL24XG 16 (13) 1.4
LS-16/-6RP 26 (20) 1.4
LS-16/-6 8 (6) 1.2
a Results shown are the average of two to four experiments for burst
size and at least 30 plaques for plaque size.
b Burst size 5 PFU/cell determined in a single cycle replication
assay.
c Analyses of t tests for the difference of means indicate that these
viruses mainly fall into two different plaque size groups: (1) KOS, KG111,
and tkLTRZ1, and (2) UL24XB, UL24XG, and LS-16/-6RP. There was a
significant difference (P , 0.01) in plaque size between the two groups,
but there was no significant difference in plaque size between mem-
bers of a group. LS-16/-6 was indistinguishable from LS-16/6RP, but its
plaques were significantly smaller than those of the other viruses.
TABLE 2
Replication and Reactivation Phenotypes Following Corneal Inoculation of Mice
Virus
Acute replication Reactivation from latency (%)
Eyeswab titersa Ganglia titersb Cocultivationc Dissociationd Totale
KOS 5.5 6 0.5 4.7 6 1.2 6/9 (67) 20/20 (100) 26/29 (90)
LS-16/-6 2.5 6 0.6 ,0.7 0/10 (0) 0/10 (0) 0/20 (0)
LS-16/6RP 4.5 6 0.4 ,0.7 0/10 (0) 1/10 (10) 1/20 (5)
UL24XB 4.0 6 0.4 #0.7 2/20 (10) 1/36 (3) 3/56 (5)
UL24XG 4.5 6 0.2 0.7 6 1.1 0/10 (0) 2/10 (20) 2/20 (10)
tkLTRZ1 6.1 6 0.1 ,0.7 Not done 0/8 (0) 0/8 (0)
ltrTK1/Bam 6.2 6 0.3 5.3 6 0.9 Not done 15/15 (100) 15/15 (100)
a log10 mean of titers 6 standard deviation from eyeswabs obtained 1 day postinoculation (at which time titers were highest) from four or more mice.
b log10 mean of titers 6 standard deviation from four or more ganglia harvested 3 days postinoculation.
c Number of ganglia reactivating over the number of ganglia tested in a cocultivation assay. Percentage ganglia reactivating is shown in
parentheses. Pooled results of two experiments.
d Number of ganglia reactivating over the number of ganglia tested in a dissociation assay. Percentage ganglia reactivating is shown in
parentheses. Pooled results of two experiments.
e Combined results from the two reactivation assays.
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behavior of the tk–pol double mutant PKG7 (Jacobson et
al., 1995). The TK-partial, UL24 double mutant LS-16/-6RP
reactivated from only 1 of 20 ganglia (in the dissociation
assay), an efficiency much less that those of wild type
(Table 2) and the TK-partial mutant KG111, which reacti-
vates with wild-type efficiency (Coen et al., 1989a; Jacob-
son et al., 1995). The two independent UL24 single mu-
tants were also highly impaired for reactivation. Taken
together, the overall frequency of reaction of the two
mutants was 5 of 76 (7%). This represents a greater than
12-fold reduction in reactivation relative to wild-type
strain KOS.
Although UL24XB and UL24XG were independent
isolates, they were both derived from tkTRZ1. To con-
trol for the possibility that the phenotypes we ob-
served were the result of a mutation in tkLTRZ1 other
than the lacZ insertion rather than a result of the UL24
mutation, we constructed the virus ltrTK1/Bam by
marker rescue of the tkLTRZ1 lacZ insertion with the
wild-type BamHI fragment from pKOS17B2. We tested
tkLTRZ1 and ltrTK1/Bam in the mouse eye model. Both
viruses replicated to wild-type titers in the eye (Table
2). As expected, tkLTRZ1 failed to replicate in ganglia
or reactivate from latency (Table 2). In contrast, ltrTK1/
Bam replicated and reactivated in ganglia as effi-
ciently as the wild type (Table 2). Thus, there was no
evidence of mutations in tkLTRZ1 other than the lacZ
insertion that could affect the phenotypes of mutants
derived from it. Rather, because indistinguishable phe-
notypes of impaired ganglionic replication and reacti-
vation were observed with two independently derived
UL24 nonsense mutants, these phenotypes can be
ascribed to the UL24 mutations.
Levels of viral DNA and LATs
To address the question of whether a UL24 mutant
could establish a latent infection, we measured viral
DNA in ganglia from mice infected with either wild-type
strain KOS or UL24XB. Because the UL24 nonsense
mutation alters the PCR product that we have previously
used to quantify viral DNA (Katz et al., 1990; Kramer and
Coen, 1995), we used primers specific for ICP4 se-
quences instead. With these primers, we found HSV DNA
in UL24XB-infected ganglia, but at substantially lower
levels (log10 mean 6 SD, 1.9 6 0.4; n 5 9) than in
KOS-infected ganglia (3.9 6 0.4; n 5 10). We also mea-
sured LATs in a subset of these ganglia using our pre-
viously published methods (Kramer and Coen, 1995;
Chen et al., 1997; Kramer et al., 1998). LATs were present
in mutant-infected ganglia, but at lower levels (log10
mean 6 SD, 4.8 6 0.3; n 5 6) than in wild-type-infected
ganglia (log10 mean 6 SD 5.9 6 0.3; n 5 9). Thus,
although there were viral nucleic acids in ganglia of mice
infected with UL24XB, their levels were low compared
with those of wild-type virus.
DISCUSSION
We discuss our results first in terms of the effects of
the different mutations on replication in cell culture and
in the mouse eye and then in terms of effects on pro-
ductive ganglionic infection.
Replication in cell culture and the mouse eye
Earlier work reporting effects of UL24 mutations on
viral replication examined either UL24–tk double mutants
or UL24–tk–pol triple mutants (Jacobson et al., 1989;
Sanders et al., 1982); thus, it was possible that the small
plaque and reduced replication phenotypes of these
UL24 mutants required the presence of additional muta-
tions. The nearly identical behaviors of UL24XB and
UL24XG and the double mutant makes this possibility
extremely unlikely (Table 1). Thus, we conclude that a
UL24 mutation by itself can decrease virus replication
and plaque size. Our results contrast with those of Tog-
non et al. (1990) who found that a TK-competent, UL24
syncytical mutant replicated as efficiently as wild-type
virus. Possible explanations for this discrepancy include
the presence of compensating mutations in this mutant,
which was known to harbor other syncytial mutations, or
that the UL24 mutation, although conferring a syncytial
phenotype, did not abrogate UL24 function as completely
as the mutations studied here.
The UL24 single mutants and the TK-partial, UL24
double mutant studied here also exhibited 10- to 30-fold
reductions in replication in the mouse eye. However, in
this tissue the UL24–tk–pol triple mutant LS-16/-6 exhib-
ited peak titers that were 100-fold lower than the TK-
partial, UL24 double mutant. This indicates that the pol
mutation in LS-16/-6 plays a role in this reduction. How-
ever, the reduction may require the UL24 mutation as the
pol and tk mutations alone or together have little or no
impact on replication at this site (Jacobson et al., 1995),
suggesting a synergistic interaction between UL24 and
pol mutations for replication in the eye. This may be
related to the reduced burst and plaque sizes of LS-16/-6
in cell culture, relative to the double mutant (Table 1),
although clearly the differences in cell culture, which
were not statistically significant, were less dramatic than
those in the eye.
TK-partial, UL24 double mutants resemble TK2
mutants in mouse ganglia
The TK-partial, UL24 double mutant LS-16/-6RP repli-
cated only slightly less well than did wild-type virus in the
mouse eye, but did not replicate detectably in the trigem-
inal ganglia. It reactivated from infected ganglia very
infrequently with only one reactivation observed in 20
ganglia. This is a dramatically different phenotype than
the unimpaired phenotype exhibited by its TK-partial mu-
tant parent KG111 (Coen et al., 1989a; Jacobson et al.,
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1995), where the alteration in the tk gene does not affect
the UL24 open reading frame. Rather, the double mutant
exhibited a phenotype approaching that of TK2 mutants
from strain KOS which replicate well in the eye and
undetectably in the ganglia, and do not reactivate from
latent infection (Coen et al., 1989b; Jacobson et al., 1993).
This similarity in phenotype may be relevant to a number
of reports in the literature in which possible or probable
UL24–tk double mutants were used to examine the role
of TK in a mammalian host (Ho and Mocarski, 1988; Leist
et al., 1989; Meignier et al., 1988; Sears et al., 1985). It
may be that the failure of some of these mutants to
reactivate from latency in mouse ganglia was due as
much or more to the UL24 defect as to the tk defect.
Importance of UL24 in the trigeminal ganglia
Although the UL24 single mutants UL24XB and
UL24XG were only modestly defective for replication in
the mouse eye, they failed to replicate in or reactivate
from all but a few of the trigeminal ganglia tested. Be-
cause these two mutants were derived independently
and exhibited indistinguishable phenotypes and be-
cause the control virus ltrTK1/Bam was indistinguishable
from wild-type virus, the observed phenotypes of UL24XB
and UL24XG can be attributed to the UL24 mutation
present in both viruses. Thus, while UL24 is not abso-
lutely essential for ganglionic replication or reactivation,
it is nearly so. UL24XB-infected ganglia contained viral
DNA and LATs, but at levels substantially less than
wild-type-infected ganglia. Inasmuch as the presence of
viral DNA and LATs reflects establishment of latency,
then, UL24XB qualitatively was able to establish latency.
Nevertheless, the low levels of viral DNA and LATs sug-
gest that UL24XB was quantitatively impaired for estab-
lishment of latency—perhaps due to defects in replica-
tion during the acute phase of infection—and that this
could contribute to its failure to reactivate from most
ganglia. Alternatively, the defect in reactivation could be
largely due to a requirement for UL24 in reactivation per
se or there could be a requirement for UL24 for both
establishment and reactivation.
UL24 was clearly much more important in infections of
ganglia than in the eye. One possible explanation for this
difference could be temperature differences between the
eye and ganglion, as has been suggested for a ribonu-
cleotide reductase mutant (Jacobson et al., 1989). How-
ever, unlike ribonucleotide reductase mutants (Goldstein
and Weller, 1988), UL24 mutants replicate comparably at
37 and 39°C in cell culture (J. G. Jacobson and D. M.
Coen, unpublished results). More likely, the difference in
levels of replication seen in the eye and in the ganglion
reflects a difference in the requirements for UL24 in
different cell types, with neurons lacking factors that can
compensate for loss of UL24 function.
It is informative to compare the effect of mutations in
UL24 with effects of certain other HSV mutations studied
in the mouse eye model. UL24 single mutants appear to
replicate slightly less well in the mouse eye than do
TK-partial, and certain drug-resistant pol mutants, but
much worse in ganglia (Coen et al., 1989a,b; Jacobson et
al., 1995, 1993; Pelosi et al., 1997; E. Pelosi and D. M.
Coen, unpublished results). Perhaps most interesting,
UL24 single mutants replicate more efficiently in the
mouse eye than do ICPO mutants, yet replicate substan-
tially less well in ganglia and reactivate substantially less
frequently than do ICPO mutants (Cai et al., 1993). This
comparison suggests that UL24 could be more important
than ICP0 in the setting of mouse ganglia. Further stud-
ies are required to elucidate the role of UL24 in gangli-
onic infection.
MATERIALS AND METHODS
Plasmids
pKOS17B2 contains the HSV-1 KOS 3.6-kb BamHI P
fragment inserted into the BamHI site of pBR325 (Weller
et al., 1983). pKOS17B2Xba was constructed by lineariz-
ing pKOS17B2 at the BglII site (see Fig. 1), filling in the
overhang using Klenow fragment, and ligating a single
14-bp XbaI linker with nonsense codons in all reading
frames (CTAGTCTAGACTAG) using linker tailing (Lathe et
al., 1984).
Cells and viruses
African green monkey kidney cells (Vero) were propa-
gated as described (Weller et al., 1983). Viruses used in
this study were wild-type HSV-1 strain KOS and mutant
and recombinant viruses derived from KOS (Table 3).
LS-16/-6 (Coen et al., 1986) contains a cluster of point
mutations in UL24 that also alter tk promoter sequences
(between the TATA box and the cap site; see Fig. 1), but
do not affect tk expression (Coen et al., 1986; Jacobson et
al., 1989). LS-16/-6 also contains a nonsense mutation
within the tk gene derived from mutant KG111 that leads
to expression of low levels of a truncated but otherwise
active TK polypeptide due to initiation at the second AUG
codon (Coen et al., 1989a; Irmiere et al., 1989) and a DNA
polymerase (pol) mutation derived from mutant PAAr5
that alters sensitivity to phosphonoacetic acid (PAA),
aphidicolin, and other drugs (Gibbs et al., 1988). Recom-
binant virus tkLTRZ1 (Davar et al., 1994) contains the
Escherichia coli lacZ gene under the control of the Molo-
ney murine leukemia virus long terminal repeat promoter
inserted into a PstI site in tk distant from UL24; the virus
is thus TK2 and forms blue plaques in the presence of
300 mg/ml X-gal.
Viruses LS-16/-6RP, UL24XB, UL24XG, and ltrTK1/Bam
were generated by marker rescue as described below.
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Construction of UL24 mutants by marker rescue
To construct UL24XB and UL24XG, infectious
tkLTRZ1 DNA was cotransfected into cells with BamHI
cut pKOS17B2Xba as described (Chiou et al., 1985). To
construct ltrTK1/Bam, infectious tkLTRZ1 was cotrans-
fected into cells with BamHI cut pKOS17B2. Progeny
from these transfections were titered on Vero cells in
the presence of 300 mg/ml X-gal. White plaques were
picked, DNA was prepared as described (Coen et al.,
1986), and tk sequences were amplified by polymer-
ase chain reaction as described (Coen, 1990) using
two primer pairs. One primer pair consisted of tk-1
(Kramer and Coen, 1995), which anneals upstream of
the BglII site in the 59 untranslated region of the tk
gene and TK5 (Hwang et al., 1994) that anneals within
tk coding sequences, and the other pair consisted of
TK7 (AGGAGCTTCAGGGAGT), which corresponds to
nucleotides 2220 to 2203, and TK8 (ACCGAAC-
CCCGCGTTTATGAACAAC), which corresponds to nu-
cleotides 1348 to 1327 of the KOS tk gene (Irmiere et
al., 1989). Amplified DNA was digested with BglII and
XbaI enzymes and electrophoresed on a 0.8% agarose
gel. Viruses from independent transfections with
pKOS17B2Xba that contained a novel XbaI site and
lacked the lacZ insertion were plaque purified three
times to produce the independent isolates UL24XB
and UL24XG. Virus from transfections with pKOS17B2
that showed loss of the lacZ insertion was plaque
purified three times to produce ltrTK1/Bam.
The UL24-tk double mutant LS-16/-6RP was con-
structed by cotransfecting LS-16/-6 infectious DNA with
the 1.7-kb KpnI fragment from the wild-type pol gene to
rescue the PAAr5 pol mutation (Gibbs et al., 1985). Prog-
eny virus was titered in the presence of aphidicolin to
select for the loss of hypersensitivity to aphidicolin (Coen
et al., 1983). Plaques that grew in the presence of 0.5
mg/ml aphidicolin were picked, plaque purified three
times, and tested for sensitivity to PAA as described
(Coen et al., 1985). One plaque-purified isolate, which
exhibited wild-type sensitivity to PAA, was designated
LS-16/6RP. Virion DNA from this isolate, prepared as
described (Hwang et al., 1994), was PCR-amplified using
primers 2655R and 3389L (Chiou et al., 1995), which flank
the site of mutation in PAAr5 and cloned Pfu DNA poly-
merase (Stratagene, La Jolla, CA) according to the man-
ufacturer’s protocol. The relevant PCR-product was puri-
fied using the Advantage PCR-pure kit (Clontech, Palo
Alto, CA) and sequenced on both strands using the PCR
primers by the Biopolymers facility of the Department of
Biological Chemistry and Molecular Pharmacology, Har-
vard Medical School, using an ABI sequencer.
Thymidine kinase activity assay
Mock-infected and infected cell extracts were pre-
pared as described (Coen and Schaffer, 1980) except
that cells were resuspended in 0.5 ml of 10 mM so-
dium phosphate buffer, pH 6, 10% glycerol, 5 mM
b-mercaptoethanol, and 50 mM thymidine before son-
ication. An aliquot of each extract or resuspension
buffer was added to an ice-cold mixture containing
final concentrations of 100 mM sodium phosphate, pH
6, 10 mM ATP, 10 mM magnesium acetate, 1.2 mCi
[3H-]thymidine (50 Ci/mmol), 40 mM TTP, and 100
mg/ml bovine serum albumin, kept on ice. The reaction
was initiated by transfer to a 30°C water bath. Aliquots
were removed at 0, 30, 60, and 120 min after addition
of the cell extract, added to 20 ml of 1 mM thymidine,
and boiled for 2 min. Samples were centrifuged briefly
and spotted onto Whatman DE81 paper. After drying,
the paper was washed three times with 4 mM ammo-
nium formate and 10 mM thymidine, once with distilled
water, and twice with ethanol. The paper was allowed
to dry and placed in a scintillation vial with betafluor
and the radioactivity was measured by scintillation
counting. The TK activity of the infected cell extracts
was normalized to their protein concentration, as de-
termined by the Bradford method (Bradford, 1976).
TABLE 3
Genotypes of Viruses in This Study
Virus Genotypea Effects on viral proteinsb
KOS wt None
KG111 tk amber 44 Low levels of truncated, but active TK
LS-16/-6 tk amber 44, UL24 LS 61-65, pol R842S Low levels of truncated, but active TK, altered UL24, Pol
LS-16/6RP tk amber 44, UL24 LS 61-65 Low levels of truncated, but active TK, altered UL24
UL24XB UL24 C52L, G53V, amber 54 Truncated UL24
UL24XG UL24 C52L, G53V, amber 54 Truncated UL24
tkLTRZ1 tk lacZ insertion 249 Truncated TK
ltrTK1/Bam Rescued tk lacZ insertion of tkLTRZ1 None
a This column provides the gene in which a known mutation lies, the codon at which the mutation occurs, and the nature of the mutation (LS, linker
scanning; R842S indicates an arginine to serine substitution).
b This column indicates the known (for TK and Pol) and predicted (for UL24) effects of the mutations on the protein products of the mutated genes.
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Southern blot analysis
Viral DNA was prepared as described (Coen et al.,
1986) and digested with BamHI, with BamHI and BglII, or
with BamHI and XbaI. The DNA was blotted and probed
with BamHI cut pKOS17B2 as described (Marcy et al.,
1990).
Single cycle replication assays
Single cycle replication assays were performed as
described (Jacobson et al., 1989).
Measurement of plaque size
Crystal violet-stained plaques from a plaque assay
(Coen et al., 1985) were measured at their widest point
using dental calipers. At least 30 plaques were mea-
sured for each virus and the mean plaque size was
calculated. The data were analyzed using a t test.
Assays of acute and latent infections in mice
Assays for replication in the mouse eye and trigeminal
ganglia and for reactivation by cocultivation and by dis-
sociation following corneal inoculation of CD-1 mice
(Charles River Breeding Laboratories) were performed
as described (Coen et al., 1989a; Leib et al., 1989, 1991).
Quantification of viral DNA and latency-associated
transcripts
PCR-based measurements of viral DNA and latency-
associated transcripts were performed as previously de-
scribed (Kramer and Coen, 1995; Chen et al., 1997;
Kramer et al., 1998) except that ganglionic DNA and viral
DNA standards were amplified using primers 4-1 and 4-2
and PCR products were detected by hybridization with
primer 4-3 to measure ICP4 sequences (Kramer and
Coen, 1995).
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